Tirzepatide, known as LY 3298176, is a dual GIP and GLP-1 receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Reagent grade, for research purpose.
Usually ships within 24 hours.